PDE5 inhibitor drugs for use in dementia is a research paper published in Alzheimer s & Dementia Translational Research & Clinical Interventions (2023). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
British Heart Foundation
Grant: PG/20/10397
British Heart Foundation
Grant: SP/F/22/150042
National Institutes of Health
Grant: U01 AG066722
National Institutes of Health
Grant: RF1 AG055125
National Institutes of Health
Grant: R01NS110024
National Institutes of Health
Grant: RF1NS119438
National Institutes of Health
Grant: R01AG067598
National Institutes of Health
Grant: R01AG07266
U.S. Department of Defense
Grant: AZ200093
Alzheimer's Association
Grant: ALZDISCOVERY‐1051936
NIA NIH HHS
Grant: R01 AG066707
NIA NIH HHS
Grant: R01 AG082118
NIA NIH HHS
Grant: RF1 AG082211
NIA NIH HHS
Grant: K08 AG065463
NIA NIH HHS
Grant: R21 AG083003
NIA NIH HHS
Grant: R56 AG074001
NIA NIH HHS
Grant: R01 AG076448
CSRD VA
Grant: IK2 CX002180
NIA NIH HHS
Grant: U01 AG073323
Medical Research Council
Grant: MR/T033371/1
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine
National Institutes of Health
Grant: 1R13AG013039-01
1995 SUMMER INSTITUTE IN GERIATRIC MEDICINE
National Institutes of Health
Grant: 1RF1AG055125-01A1
The role of methylation-sensitive PP2A isoforms in regulating the pathological response to tau
National Institutes of Health
Grant: 5R01AG082118-02
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
National Institutes of Health
Grant: 5U01AG073323-05
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
National Institutes of Health
Grant: 5R01AG076448-03
TREM2 Genotype-Informed Drug Repurposing and Combination Therapy Design for Alzheimers Disease
National Institutes of Health
Grant: 1R56AG074001-01
Multimodal single-cell genomic and epigenomic analyses elucidate Alzheimer’s sexual dimorphism in human immune systems aging
National Institutes of Health
Grant: 5R01NS110024-05
The Role of SUMOylation in Tau-Mediated Pathology
National Institutes of Health
Grant: 1U01AG066722-01
Preclinical development of a novel small molecule inhibitor of Alzheimer's disease-related cognitive impairment
National Institutes of Health
Grant: 1R21AG083003-01
Precision Medicine Digital Twins for Alzheimer’s Target and Drug Discovery and Longevity
National Institutes of Health
Grant: 1RF1AG082211-01
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
National Institutes of Health
Grant: 5R01AG067598-04
Chaperome networks in Alzheimer's disease
National Institutes of Health
Grant: 1RF1NS119438-01A1
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta
National Institutes of Health
Grant: 5R01AG066707-04
Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimers Disease
UK Research and Innovation
Grant: MR/R005567/1
Pathomolecular mechanisms of intracerebral haemorrhage: functional analysis of collagen IV variants.
National Institutes of Health
Grant: 5IK2CX002180-02
A Precision Medicine Approach To Study Targetable Pathways in Vascular Dementia
Larry L. Hillblom Foundation
Chan Zuckerberg Initiative
Rainwater Charitable Foundation
FWCI
1.69
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals